Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
Public ClinicalTrials.gov record NCT02971683. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Abatacept SC With Standard Treatment Compared to Standard Treatment Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy (IIM)
Study identification
- NCT ID
- NCT02971683
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 149 participants
Conditions and interventions
Conditions
Interventions
- Abatacept subcutaneous Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 3, 2017
- Primary completion
- Jul 26, 2020
- Completion
- Aug 1, 2022
- Last update posted
- Oct 29, 2023
2017 – 2022
United States locations
- U.S. sites
- 25
- U.S. states
- 20
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0015 | Phoenix | Arizona | 85028 | — |
| Local Institution - 0075 | Beverly Hills | California | 90211 | — |
| Local Institution - 0012 | Orange | California | 92868 | — |
| Local Institution - 0057 | Washington D.C. | District of Columbia | 20037 | — |
| Local Institution - 0018 | Fort Lauderdale | Florida | 33309 | — |
| Local Institution - 0013 | Miami | Florida | 33136 | — |
| Local Institution - 0006 | Kansas City | Kansas | 66160 | — |
| Johns Hopkins University -Johns Hopkins Bayview Medical Center | Baltimore | Maryland | 21224 | — |
| Local Institution - 0058 | Boston | Massachusetts | 02115 | — |
| Local Institution - 0089 | Ann Arbor | Michigan | 48109 | — |
| Local Institution - 0002 | Eagan | Minnesota | 55121 | — |
| Local Institution - 0011 | Omaha | Nebraska | 68198-3025 | — |
| Local Institution - 0004 | Lebanon | New Hampshire | 03756 | — |
| Local Institution - 0097 | New York | New York | 10021 | — |
| Local Institution - 0010 | Wilmington | North Carolina | 28401 | — |
| Local Institution - 0056 | Columbus | Ohio | 43203 | — |
| Local Institution - 0094 | Middleburg Heights | Ohio | 44130 | — |
| Local Institution - 0059 | Norman | Oklahoma | 73072 | — |
| Local Institution - 0055 | Bethlehem | Pennsylvania | 18015 | — |
| Local Institution - 0014 | Pittsburgh | Pennsylvania | 15213 | — |
| Local Institution - 0005 | Orangeburg | South Carolina | 29118 | — |
| Local Institution - 0017 | Jackson | Tennessee | 38305 | — |
| Local Institution - 0096 | Austin | Texas | 78756 | — |
| Local Institution - 0016 | Houston | Texas | 77030 | — |
| Local Institution - 0095 | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02971683, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 29, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02971683 live on ClinicalTrials.gov.